↓ Skip to main content

Cochrane Database of Systematic Reviews

Perazine for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, January 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (75th percentile)

Mentioned by

twitter
3 X users
facebook
1 Facebook page
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
188 Mendeley
Title
Perazine for schizophrenia
Published in
Cochrane database of systematic reviews, January 2014
DOI 10.1002/14651858.cd002832.pub3
Pubmed ID
Authors

Stefan Leucht, Bartosz Helfer, Benno Hartung

Abstract

Perazine is an old phenothiazine derivative used for the treatment of people with schizophrenia and is reputed to have a low level of extrapyramidal adverse effects. As far as we are aware, its use is limited to Germany, Poland, the former Yugoslavia and the Netherlands.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 188 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Unknown 187 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 33 18%
Student > Ph. D. Student 25 13%
Researcher 20 11%
Student > Bachelor 15 8%
Student > Doctoral Student 12 6%
Other 37 20%
Unknown 46 24%
Readers by discipline Count As %
Medicine and Dentistry 64 34%
Psychology 20 11%
Nursing and Health Professions 17 9%
Pharmacology, Toxicology and Pharmaceutical Science 10 5%
Unspecified 7 4%
Other 20 11%
Unknown 50 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 April 2019.
All research outputs
#6,272,216
of 22,757,090 outputs
Outputs from Cochrane database of systematic reviews
#8,085
of 12,314 outputs
Outputs of similar age
#80,965
of 329,890 outputs
Outputs of similar age from Cochrane database of systematic reviews
#177
of 244 outputs
Altmetric has tracked 22,757,090 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 12,314 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one is in the 33rd percentile – i.e., 33% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 329,890 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 244 others from the same source and published within six weeks on either side of this one. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.